Cargando…

Immunomodulatory intervention in sepsis by multidrug-resistant Pseudomonas aeruginosa with thalidomide: an experimental study

BACKGROUND: Thalidomide is an inhibitor of tumour necrosis factor-alpha (TNFα) that has been proven effective for the treatment of experimental sepsis by Escherichia coli. It was tested whether it might behave as an effective immunomodulator in experimental sepsis by multidrug-resistant (MDR) Pseudo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giamarellos-Bourboulis, Evangelos J, Bolanos, Nikolaos, Laoutaris, George, Papadakis, Vassilios, Koussoulas, Vassilios, Perrea, Despina, Karayannacos, Panayotis E, Giamarellou, Helen
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1185538/ https://www.ncbi.nlm.nih.gov/pubmed/15978135 http://dx.doi.org/10.1186/1471-2334-5-51

Ejemplares similares

Clarithromycin is an effective immunomodulator when administered late in experimental pyelonephritis by multidrug-resistant Pseudomonas aeruginosa
por: Giamarellos-Bourboulis, Evangelos J, et al.
Publicado: (2006)

Immunomodulatory effects of esmolol in a septic animal model due to multidrug-resistant Pseudomonas aeruginosa pyelonephritis
por: Dimopoulos, G, et al.
Publicado: (2008)

Early apoptosis of blood monocytes in the septic host: is it a mechanism of protection in the event of septic shock?
por: Giamarellos-Bourboulis, Evangelos J, et al.
Publicado: (2006)

Multiple trauma is linked with reversal of immunoparalysis and provides survival benefit from Pseudomonas aeruginosa
por: Mandragos, E, et al.
Publicado: (2014)

Association between genotypes of rs34436714 of NLRP12 and serum tumor necrosis factor-alpha in inflammatory bowel disease: A case-control study
por: Dellaporta, Erminia, et al.
Publicado: (2019)

Compartmentalization of lipid peroxidation in sepsis by multidrug-resistant gram-negative bacteria: experimental and clinical evidence
por: Toufekoula, Chryssoula, et al.
Publicado: (2013)

Decrease of CD4-lymphocytes and apoptosis of CD14-monocytes are characteristic alterations in sepsis caused by ventilator-associated pneumonia: results from an observational study
por: Pelekanou, Aimilia, et al.
Publicado: (2009)

Host cystathionine-γ lyase derived hydrogen sulfide protects against Pseudomonas aeruginosa sepsis
por: Renieris, Georgios, et al.
Publicado: (2021)

Effect of Triiodothyronine Administration on the Kidney During Haemorrhagic Shock and Resuscitation
por: Karmaniolou, Iosifina, et al.
Publicado: (2020)

The prevalence of Pseudomonas aeruginosa and multidrug resistant Pseudomonas aeruginosa in healthy captive ophidian
por: Sala, Andrea, et al.
Publicado: (2019)

Effect of methylglyoxal on multidrug-resistant Pseudomonas aeruginosa
por: Hayashi, Katsuhiko, et al.
Publicado: (2014)

Multidrug resistant Pseudomonas aeruginosa in Estonian hospitals
por: Telling, Kaidi, et al.
Publicado: (2018)

Diagnostic value of triggering receptor expressed on myeloid cells-1 and C-reactive protein for patients with lung infiltrates: an observational study
por: Porfyridis, Ilias, et al.
Publicado: (2010)

Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis
por: Karakike, Eleni, et al.
Publicado: (2019)

Early changes of CD4-positive lymphocytes and NK cells in patients with severe Gram-negative sepsis
por: Giamarellos-Bourboulis, Evangelos J, et al.
Publicado: (2006)

Kinetics of progenitor hemopoetic stem cells in sepsis: Correlation with patients survival?
por: Tsaganos, Thomas, et al.
Publicado: (2006)

MexXY multidrug efflux system of Pseudomonas aeruginosa
por: Morita, Yuji, et al.
Publicado: (2012)

Emergence and Spread of Epidemic Multidrug-Resistant Pseudomonas aeruginosa
por: Miyoshi-Akiyama, Tohru, et al.
Publicado: (2017)

Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
por: Kunz Coyne, Ashlan J., et al.
Publicado: (2022)

A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
por: Mohamed, Mohamed F., et al.
Publicado: (2017)

Editorial Introduction to the Supplement “Diagnosis of Infectious Diseases by Detection of Microbial Pathogens: A Joint Session Between HemoSpec FrameWork 7 Consortium with COST Action BM1401 Raman4Clinics Working Group 2”
por: Giamarellos-Bourboulis, Evangelos J.
Publicado: (2018)

Complex immune deregulation in severe COVID-19: More than a mechanism of pathogenesis
por: Giamarellos-Bourboulis, Evangelos J.
Publicado: (2021)

Immunomodulatory effects of thalidomide in an experimental brain death liver donor model
por: Santana, Alexandre Chagas, et al.
Publicado: (2021)

Carbapenem Susceptibility and Multidrug-Resistance in Pseudomonas aeruginosa Isolates in Egypt
por: Hashem, Hany, et al.
Publicado: (2016)

S33.1 Multidrug-resistant Acinetobacter baumanii and Pseudomonas aeruginosa
Publicado: (2005)

Exposure of Pseudomonas aeruginosa to Cinnamaldehyde Selects Multidrug Resistant Mutants
por: Tetard, Alexandre, et al.
Publicado: (2022)

Sepsis: Diagnostic and Therapeutic Challenges
por: Molnár, Zsolt, et al.
Publicado: (2016)

Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects
por: Dredge, K, et al.
Publicado: (2002)

The complex pathogenesis of bacteremia: From antimicrobial clearance mechanisms to the genetic background of the host
por: Christaki, Eirini, et al.
Publicado: (2014)

Antimicrobial Stewardship Using Biomarkers: Accumulating Evidence for the Critically Ill
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2022)

Multidrug Efflux Systems Play an Important Role in the Invasiveness of Pseudomonas aeruginosa
por: Hirakata, Yoichi, et al.
Publicado: (2002)

Polimixin B use in treatment of multidrug-resistant Pseudomonas aeruginosa infection
por: Gouveia, LS, et al.
Publicado: (2003)

Multidrug Resistant Pseudomonas aeruginosa in Iran: A Systematic Review and Metaanalysis
por: Vaez, Hamid, et al.
Publicado: (2018)

Gene regulatory network inference and analysis of multidrug-resistant Pseudomonas aeruginosa
por: Medeiros, Fernando, et al.
Publicado: (2019)

Association of multidrug resistance behavior of clinical Pseudomonas aeruginosa to pigment coloration
por: Kothari, Ashish, et al.
Publicado: (2022)

Effects of the order of exposure to antimicrobials on the incidence of multidrug-resistant Pseudomonas aeruginosa
por: Yasuda, Nami, et al.
Publicado: (2023)

Systemic Immunomodulatory Effects of Combinatorial Treatment of Thalidomide and Dexamethasone on T Cells and Other Immune Cells
por: Kim, Eun Jee, et al.
Publicado: (2021)

Design, synthesis, and biological evaluation of novel bioactive thalidomide analogs as anticancer immunomodulatory agents
por: Kotb, Anas Ramadan, et al.
Publicado: (2022)

Evaluation of Rapid Polymyxin Pseudomonas test in clinical Pseudomonas aeruginosa isolates with various degrees of multidrug resistance
por: Sánchez-López, Javier, et al.
Publicado: (2021)

Relationship between the Presence of the nalC Mutation and Multidrug Resistance in Pseudomonas aeruginosa
por: Sadeghifard, Nourkhoda, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ir9ln7arh2b2qpq2uua7uh7dkr